Atoltivimab, CAS 2135632-29-8

Product Description: Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Saxena D, et al. Atoltivimab/maftivimab/odesivimab (Inmazeb) combination to treat infection caused by Zaire ebolavirus. Drugs Today (Barc). 2021 Aug;57(8):483-490.

CAS Number: 2135632-29-8

Molecular Weight: N/A

Compound Purity: 98.66

Research Area: Infection

Solubility: 10 mM in DMSO

Target: Filovirus

• SKU: MEXHY-P99343-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99343-5
• Green Labware: No
• Package Unit: 5 mg
• Quantity Unit: STK